| Date | Title | Description |
| 16.01.2024 | Stalicla Secures $17.4 Million in Series B Financing | - |
| 16.01.2024 | Prota Therapeutics US $21 Million Financing Led by SPRIM Glo... | Financing advances development of Prota’s peanut allergy remission therapy in preparation for a Phas... |
| 02.11.2023 | RegASK Welcomes New Chief Product & Technology Officer | NEW YORK and SINGAPORE, Nov. 2, 2023 — RegASK, a global regtech SaaS platform that enables businesse... |
| 17.10.2023 | ObvioHealth Strengthens Leadership Team with Key Industry Ap... | - |
| 10.10.2023 | Fibronostics Announces Partnership with Stone Diagnostics | - |
| 29.09.2023 | Spexis provides business update and announces financial resu... | Ad hoc announcement pursuant to Art. 53 LR
ALLSCHWIL, Switzerland, Sept. 28, 2023 (GLOBE NEWSWIRE) ... |
| 14.08.2023 | Spexis announces USD $2.5 million capital commitment to supp... | ALLSCHWIL, Switzerland, Aug. 14, 2023 (GLOBE NEWSWIRE) — Spexis AG (SIX: SPEX), a clinical-stage bio... |
| 14.07.2023 | Readout AI Secures Pre-Seed Funding to Decrease the Time fro... | - |
| 26.05.2023 | SPRIM Global Investments Pte. Ltd. completes equity investme... | - |
| 03.05.2023 | ObvioHealth Signs R&D Partnership with A*STAR to Identif... | - |
| 18.04.2023 | Spexis announces closing of capital commitment of USD 4.5 mi... | Ad hoc announcement pursuant to Art. 53 LR
ALLSCHWIL, Switzerland, April 18, 2023 (GLOBE NEWSWIRE) ... |
| 06.04.2023 | AUM Biosciences, SCG Cell Therapy, Blood And Hello Health Di... | AUM Biosciences, a Singapore-headquartered biotech company focused on precision oncology therapeutic... |
| 28.03.2023 | 1nHealth Launches Site Advisory Board to Prioritize Site Voi... | ORLANDO, Fla., March 28, 2023 (Newswire.com) – Today, 1nHealth launched its Site Advisory Board, a c... |
| 27.03.2023 | STALICLA and Firefly Neuroscience enter Partnership Agreemen... | STALICLA and Firefly Neuroscience enterPartnership Agreement for the Development of Electroencephalo... |
| 16.03.2023 | ObvioHealth to Conduct a Pioneering Decentralized Clinical T... | NEW YORK, March 16, 2023 /PRNewswire/ — ObvioHealth and Mi-Helper, Inc. announce a partnership to co... |
| 09.02.2023 | Jaguar Health Announces Initial Close in Private Placement F... | This closing on funds from SPRIM Global Investments, a healthcare-focused international venture capi... |
| 08.02.2023 | Spexis and SPRIM Global Investments (SGI) Announce Plans for... | ALLSCHWIL, Switzerland, Feb. 08, 2023 (GLOBE NEWSWIRE) — Spexis AG (SIX: SPEX), a clinical-stage bio... |
| 09.01.2023 | STALICLA signs exclusive in-licensing agreement for late-sta... | PRESS RELEASE
Geneva, SWITZERLAND – 9 January 2023, STALICLA SA, a clinical-stage biotech company a... |
| 15.12.2022 | RegASK announces US$10m Series A Funding Round led by Monogr... | SINGAPORE, Dec. 15, 2022 /PRNewswire/ — RegASK, a global RegTech SaaS company, today announced it ha... |
| 20.10.2022 | AUM Biosciences, a Global Biotechnology Company Developing P... | SINGAPORE and NEW YORK, Oct. 20, 2022 (GLOBE NEWSWIRE) — AUM Biosciences Pte. Ltd. (“AUM”), a clinic... |
| 12.10.2022 | Stalicla SA and Evgen Pharma plc ink $160.5m licensing deal ... | - |
| 18.08.2022 | AUM Biosciences Receives FDA Orphan Drug Designation for AUM... | SINGAPORE and BETHESDA, Md., Aug. 18, 2022 (GLOBE NEWSWIRE) — AUM Biosciences, a global clinical-sta... |
| 16.08.2022 | ObvioHealth Ranked on Inc. 5000’s List of Fastest Growing Pr... | NEW YORK, Aug. 16, 2022 /PRNewswire/ — ObvioHealth, a leading global Virtual Research Organization (... |
| 27.06.2022 | Treos Bio Announces First Patient Dosed in Phase 2 Trial of ... | LONDON, June 27, 2022 (GLOBE NEWSWIRE) — Treos Bio Limited (“Treos”), a clinical stage biotechnology... |
| 15.06.2022 | Fibronostics Secures Financing, Announces New CEO | NEW YORK and SINGAPORE, June 15, 2022 /PRNewswire/ — Fibronostics, a global leader in non-invasive, ... |
| 02.04.2022 | LIVERFASt can be better than the gold standard liver biopsy,... |
This final part of the video informative series focuses on LIVERFASt, a non-invasive AI driven tec... |
| 05.03.2022 | Faster, safer, more accurate trials. | ObvioHealth is pioneering new ways to collect clinical trial data. Their innovative platform seamles... |
| 08.02.2022 | SPRIM Global Investments names Susan Dallabrida as Chief Exe... | SPRIM Global Investments announces the promotion of Susan Dallabrida, PhD, to Chief Executive Office... |
| 08.12.2021 | The Digital Health 150: The Top Digital Health Companies Of ... | CB Insights has unveiled the third annual Digital Health 150 — a list of 150 of the top private comp... |
| 16.11.2021 | GHO Capital Acquires Genesis Research, a Pioneer in Tech-ena... | - |
| 12.10.2021 | AUM Biosciences announces closing of $27 million in a “Serie... | SINGAPORE and NEW YORK, October 12, 2021 – AUM Biosciences (AUM) today announced the successful comp... |
| 14.09.2021 | ObjectiveGI Announces Name Change to ObjectiveHealth | - |
| 01.07.2021 | ObvioHealth Raises $31 Million, Adds Two Strategic Partners ... |
NEW YORK –July 1, 2021 – ObvioHealth, a global Virtual Research Organization(VRO), announces it ha... |
| 07.06.2021 | ObvioHealth Announces a Groundbreaking Partnership with Deda... |
NEW YORK – June 7, 2021 – ObvioHealth, a global virtual research organization (VRO), is bringing... |
| 01.03.2021 | Leveraging Next-Gen Tools in Rare Disease Research | The capture of high-quality, accurate and complete datasets in a clinical trial is always of utmost ... |
| 07.01.2021 | Genesis Research Announces Acquisition of Evid Science | HOBOKEN, N.J. (PRWEB) JANUARY 07, 2021
Genesis Research LLC (GR), a Value Demonstration Company pro... |
| 24.08.2020 | Fibronostics Raises $8 Million in Series A Financing | - |
| 05.08.2020 | Fibronostics Appoints Dr. Stephen A. Harrison to its Board o... | - |
| 23.06.2020 | The Critical Need for Virtual COVID-19 Clinical Trials and P... | The FDA recently released new guidance on drug development for the prevention and treatment of COVID... |
| 18.06.2020 | ObvioHealth and Hôpital Paris Saint-Joseph Announce Partners... | - |
| 11.06.2020 | Travecta Therapeutics Announces it has Closed its Oversubscr... | - |
| 08.06.2020 | SPRIM Partners with Health Catalyst to Analyze COVID-19 Impa... | - |
| 20.05.2020 | ObvioHealth Secures $17 Million in Latest Investment Round | - |
| 12.05.2020 | Travecta Therapeutics Secures $15 Million in Financing | - |
| 10.02.2020 | Ventures Day Singapore 2020: Post-event highlights | Following our three successful past events – June 2017 & January 2019 in Singapore and April 201... |
| 07.06.2019 | AC Health Announces Investment in Fibronostics | Ayala Healthcare Holdings, through its technology arm, Vigos, expanded its digital portfolio with a ... |
| 21.03.2019 | SPRIM’s Quarterly Ventures Day Meeting in New York | SPRIM, in partnership with Tikehau Capital, is hosting its quarterly Ventures Day meeting on April 2... |
| 29.01.2019 | Objective GI Funding Announcement |
The clinical research company establishes partnerships with gastroenterology practices and is fore... |
| 28.01.2019 | TKS 1 Investor Day 2019 in Singapore: Post Event Highlights | Following a successful Ventures Day in 2017, we are back with yet another great event organized in c... |
| 15.01.2019 | RegASK, a Healthcare RegTech Startup, Secures Venture Capita... | RegAsk uses artificial intelligence to answer regulatory questions, including inquiries about path-t... |
| 15.11.2018 | Evid Science Receives Seed Capital to Advance Clinical AI Pl... | LOS ANGELES, CA (February 15, 2018) – Evid Science, an artificial intelligence (AI) company for the ... |
| 15.11.2018 | SPRIM and Tikehau Capital Join Forces with New Singapore-bas... | LIFE science startups hoping for a big break can now look to a new Singapore-based cash cow for fund... |
| 23.03.2018 | ObvioHealth Raises $3 Million in Series A Funding | OBVIOHEALTH, a Singapore and Orlando-based company offering mobile and “site-less” clinical trials, ... |
